Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET
Clinical trial NCT05420636 · TERMINATED
Trial details
- NCT number
- NCT05420636
- Sponsor
- Fox Chase Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-21
- Primary completion
- 2025-07-23
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.